ContextVision’s second quarter sees multiple product releases including digital pathology debut
STOCKHOLM: ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, reports a progressive second quarter. INIFY Prostate Screening – the company’s first decision support tool in a planned digital pathology portfolio – was granted CE- mark…